VABS vs. BBC

Last updated Jun 24, 2026

VABS (Virtus Newfleet ABS/MBS ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both exchange-traded funds - VABS is a Mortgage Backed Securities fund actively managed by Virtus Investment Partners, while BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index. VABS is actively managed, while BBC is passively managed. Over the past 5 years, VABS returned 3.26%/yr vs -0.26%/yr for BBC. At a 0.06 correlation, their price movements are largely independent. VABS charges 0.39%/yr vs 0.79%/yr for BBC.

Performance

VABS vs. BBC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus Newfleet ABS/MBS ETF (VABS) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VABS achieves a 1.70% return, which is significantly lower than BBC's 25.75% return.

VABS

• 1D: 0.08%
• 1M: 0.45%
• YTD: 1.70%
• 6M: 1.84%
• 1Y: 3.93%
• 3Y*: 6.26%
• 5Y*: 3.26%
• 10Y*: —

BBC

• 1D: 1.59%
• 1M: 13.54%
• YTD: 25.75%
• 6M: 22.73%
• 1Y: 156.95%
• 3Y*: 27.00%
• 5Y*: -0.26%
• 10Y*: 11.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VABS vs. BBC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VABS Virtus Newfleet ABS/MBS ETF	1.70%	5.40%	7.59%	7.61%	-5.24%	0.37%
BBC Virtus LifeSci Biotech Clinical Trials ETF	25.75%	63.77%	-1.11%	-1.80%	-35.13%	-37.15%

Correlation

The correlation between VABS and BBC is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (All Time) Calculated using the full available price history since Feb 10, 2021	0.06

Return for Risk

VABS vs. BBC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VABS

VABS Risk / Return Rank: 70
VABS Sharpe Ratio Rank: 64
VABS Sortino Ratio Rank: 62
VABS Omega Ratio Rank: 79
VABS Calmar Ratio Rank: 81
VABS Martin Ratio Rank: 62

BBC

BBC Risk / Return Rank: 95
BBC Sharpe Ratio Rank: 97
BBC Sortino Ratio Rank: 95
BBC Omega Ratio Rank: 91
BBC Calmar Ratio Rank: 97
BBC Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VABS vs. BBC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus Newfleet ABS/MBS ETF (VABS) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VABS	BBC	Difference
Sharpe ratio: Return per unit of total volatility	1.97	4.36	-2.39
Sortino ratio: Return per unit of downside risk	2.70	4.70	-2.00
Omega ratio: Gain probability vs. loss probability	1.43	1.56	-0.13
Calmar ratio: Return relative to maximum drawdown	4.01	10.46	-6.45
Martin ratio: Return relative to average drawdown	10.35	30.65	-20.30

VABS vs. BBC - Sharpe Ratio Comparison

The current VABS Sharpe Ratio is 1.97, which is lower than the BBC Sharpe Ratio of 4.36. The chart below compares the historical Sharpe Ratios of VABS and BBC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VABS vs. BBC - Drawdown Comparison

The maximum VABS drawdown since its inception was -7.12%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for VABS and BBC.

Drawdown Indicators

	VABS	BBC	Difference
Max Drawdown Largest peak-to-trough decline	-7.12%	-76.85%	+69.73%
Max Drawdown (1Y) Largest decline over 1 year	-0.98%	-15.10%	+14.12%
Max Drawdown (3Y) Largest decline over 3 years	-1.42%	-54.45%	+53.03%
Max Drawdown (5Y) Largest decline over 5 years	-7.12%	-71.97%	+64.85%
Max Drawdown (10Y) Largest decline over 10 years	—	-76.85%	—
Current Drawdown Current decline from peak	-0.15%	-19.28%	+19.13%
Average Drawdown Average peak-to-trough decline	-1.40%	-37.08%	+35.68%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.38%	5.14%	-4.76%

Volatility

VABS vs. BBC - Volatility Comparison

The current volatility for Virtus Newfleet ABS/MBS ETF (VABS) is 0.37%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 12.08%. This indicates that VABS experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VABS	BBC	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.37%	12.08%	-11.71%
Volatility (6M) Calculated over the trailing 6-month period	1.06%	26.79%	-25.73%
Volatility (1Y) Calculated over the trailing 1-year period	2.01%	36.27%	-34.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	2.30%	39.52%	-37.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	2.24%	37.75%	-35.51%

VABS vs. BBC - Expense Ratio Comparison

VABS has a 0.39% expense ratio, which is lower than BBC's 0.79% expense ratio.

Dividends

VABS vs. BBC - Dividend Comparison

VABS's dividend yield for the trailing twelve months is around 5.07%, more than BBC's 1.35% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.35%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
VABS Virtus Newfleet ABS/MBS ETF	5.07%	4.94%	5.05%	4.13%	2.47%	1.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VABS and BBC in my portfolio?

VABS and BBC have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VABS or BBC?

BBC has higher volatility (12.08%) compared to VABS (0.37%). In terms of maximum drawdown, VABS dropped -7.12% vs BBC's -76.85%.

Which ETF is better, VABS or BBC?

On 5-year performance, VABS leads with 3.26% vs -0.26% for BBC. On fees, VABS is cheaper at 0.39% per year. On volatility, VABS has been the lower-risk option at 0.37%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, VABS or BBC?

Over the 5-year period, VABS has performed better with a 3.26% return vs -0.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, VABS or BBC?

VABS is cheaper with a 0.39% expense ratio, compared with 0.79% for BBC.

Which ETF pays a higher dividend yield, VABS or BBC?

VABS has the higher dividend yield at 5.07%, compared with 1.35% for BBC.

What is the main difference between VABS and BBC?

VABS is categorized as Mortgage Backed Securities, while BBC is Health & Biotech Equities. Their fees differ too: 0.39% for VABS and 0.79% for BBC.

Which has better risk-adjusted returns?

BBC currently has the higher Sharpe Ratio (4.36 vs 1.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.